Hormone clues sought in rare nerve disease

NCT ID NCT07266051

Not yet recruiting Knowledge-focused Sponsor: Xiamen Hospital of Traditional Chinese Medicine Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will measure sex hormone levels in 4000 people with NMOSD, a rare autoimmune disease affecting the nerves. Researchers want to see if hormone changes are linked to the disease. Participants will give blood samples for hormone testing. The study does not test any new drug or treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could reveal how sex hormones influence NMOSD, pointing toward new ways to manage the disease.
What could go wrong: This is an observational study, not a treatment trial. It will not directly benefit participants and may not lead to any new therapies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NMOSD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

neuromyelitis optica

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NMOSD

Contacts and locations

Locations

The First Affiliated Hospital of Xiamen university

Xiamen, Fujian, 361000, China
The Second Affiliated Hospital of Xiamen Medical College

Xiamen, Fujian, 361000, China
Xiamen Hospital of Traditional Chinese Medicine

Xiamen, Fujian, 361000, China
Zhongshan Hospital (Xiamen), Fudan University

Xiamen, Fujian, 361000, China
Zhongshan Hospital Xiamen University

Xiamen, Fujian, 361000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.